rvv

TORONTO, Aug. 12, 2021 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (Frankfurt:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces that its management is not aware of any undisclosed material information relatin... Read More...

TORONTO, Dec. 23, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinica... Read More...

TORONTO, Nov. 24, 2020 -- PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to provide a corporate update on its psychedelic pharmaceuticals program. Since its incepti... Read More...

TORONTO, Nov. 18, 2020 -- PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce it has entered into an exclusive research collaboration agreement with Revive T... Read More...

WINNIPEG, MB, Oct. 19, 2020 - Ag Growth International Inc. ("AGI") (TSX: AFN) will hold a conference call on Thursday November 12, 2020, at 8:00 a.m. EST to discuss its results for the three and six-months ended September 30, 2020. A news release announcing AGI's results will be issued before markets open on November 12, 2020.To participa... Read More...

OTCStockReview.com News CommentaryATLANTA, Oct. 16, 2020 -- 2020 has been quite a year, but hidden among the carnage is great news about advances in research on psychedelic medicine to treat mental health issues. In January Johns Hopkins announced it had launched the Center for Psychedelic and Consciousness Research three months earlier. ... Read More...

TORONTO, Oct. 8, 2020 - A settlement hearing in the matter of Stefano Arena ("Respondent") was held by electronic hearing today in Toronto, Ontario before a three-member Hearing Panel of the Central Regional Council of the Mutual Fund Dealers Association of Canada ("MFDA").The Hearing Panel accepted the settlement agreement dated August 2... Read More...

TORONTO, Aug. 05, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that following the U.S. Food & Drug Administration (“U.S. FDA”) approval to procee... Read More...

TORONTO, May 13, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide a corporate update on its pharmaceutical programs for Bucillamine in the treatment of the coronavirus... Read More...

TORONTO, April 21, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that it has entered into a sponsored research partnership agreement (“SRPA”) with the University of Wisco... Read More...